Navigation Links
Sigma-tau's Antimalarial Awarded "Project of the Year" 2011 by Medicines for Malaria Venture
Date:11/27/2012

NEW DELHI, November 27, 2012 /PRNewswire/ --

The project team for Eurartesim®, dihydroartemisinin-piperaquine (DHA-PQP), the first novel chemical entity developed by Sigma-Tau was awarded Medicines for Malaria (MMV) Project of the Year 2011, the latter is a non-profit body with significant contribution from the Bill& Melinda Gates foundation. The award was presented in new Delhi during MMV's international stakeholder meeting.

Representatives of the Italian pharma group - Prof. Trevor Jones, Dr Marco Corsi & Dr Andreas Diedenhofen - accepted the prize and expressed satisfaction on behalf of the entire team for the achievement.

MMV established the "Project of the Year" award more than a decade ago to recognize the efforts of selected teams working to combat malaria worldwide. Winners are selected by MMV's Expert Scientific Advisory Committee, a group of world renowned experts in malaria and drug development.

Having received European Medicines Agency (EMA) approval in 2011, Eurartesim can now be used safely and effectively, and be deployed widely. The first shipment of 160,000 packages of Eurartesim to a malaria-endemic country were delivered to Cambodia in July this year, where it is hoped the medicine will help to delay the development of artemisinin drug resistance emerging in the region.

The drug is already available in Europe and has a series of advantages over other artemisinin-based combination therapies (ACTs) given that it's easier to administer - once a day for three days- rather than other medicines which need to be taken twice a day. owing to the long half-life of piperaquine, Eurartesim® offers better and longer protection from new malaria infections.

Sigma-Tau Group

Sigma-Tau is a leading, all Italian capital, International pharmaceutical Group, founded in 1957, that invests in the research, development and marketing of innovative and effective treatments to improve human well-being and quality of life. Sigma-Tau Group has headquarters in Pomezia (Rome, Italy), and subsidiaries in France, Switzerland, the Netherlands, Belgium, Portugal, Germany, UK, India, and with production plant in Italy as well as in Spain and US (Indianapolis); with about 2400 employees and an extensive network of licensees worldwide achieved a global turnover of € 663 million in 2011.

Website:http://www.sigma-tau.it

Sigma-Tau Press Office Evolution
Bruno Chiavazzo, Head of Communication and Information
E-mail: bruno.chiavazzo@sigma-tau.it
Phone +39-(0)6-91393963
PR
Rudra Chakraborty
Email: rudra.chakraborty@evolutionpr.it
Phone +39-3317671004



'/>"/>
SOURCE Sigma-Tau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Reveals Extent of Poor-Quality Antimalarial Medicines in South American Countries
2. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
3. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
4. Breast Cancer Survivor Awarded Top Prize In 2012 Oncology On Canvas(SM) Art Competition
5. New Snoring Therapy Awarded The Prestigious Spark Award
6. Harrisvaccines Awarded Vaccine Product Licensure
7. Healionics Awarded $900k Grant from NIH
8. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
9. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
10. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
11. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
Breaking Medicine News(10 mins):